banner add

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.

from NYT > Health https://ift.tt/ml6TLyY
via IFTTT

No comments

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent ...

Theme images by PLAINVIEW. Powered by Blogger.